News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AVIVA Biosciences Corporation Signs Agreement With Cosmo Bio Co., Ltd For Representation In Japan


10/31/2006 10:33:10 AM

SAN DIEGO, Oct. 30 /PRNewswire/ -- AVIVA Biosciences Corporation announces the selection of Cosmo Bio Co., Ltd. as key distributor for the Japanese territory. "Cosmo Bio's leadership in providing third party drug discovery services to the Japanese pharmaceutical industry and in the distribution of products for life science research is well recognized throughout Japan. We believe that the addition of AVIVA Biosciences' expert custom electrophysiological services and its HERGEXPRESS ion channel cardiac safety assessment will significantly benefit their customers," said Dr. Andrea Ghetti, Senior Director of the Pharma Services division at AVIVA Biosciences.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030428/AVIVALOG0 )

Dr. Keiichi Yokoyama, leader of Cosmo Bio's Drug Discovery Services team, remarked, "World regulatory agencies consider ion channel cardiac safety testing as a necessary step for advancing lead compounds to the clinic. Japan is no exception. We are very excited by the opportunity to offer AVIVA Biosciences' recognized expertise and cell lines to our customers."

Additionally, AVIVA Biosciences continues to add to its service offering with the recent introduction of human heart tissue assays, human cardiac myocyte electrophysiology along with GLP-compliant study capabilities. These new services complement AVIVA Biosciences premier capacity in the industry for high quality automated electrophysiology services and the ion channel cell lines currently available to drug research and development organizations.

Based in San Diego, California, AVIVA Biosciences Corporation develops enabling drug discovery technologies by integrating cell biology and chemistry into biochips. AVIVA Biosciences products, combine unique surface chemistry with advanced design to address multiple applications dedicated primarily to automation and improved productivity of cell-based research. AVIVA Biosciences currently manufactures the disposable 16 channel version of SealChip(TM) exclusively for the automated electrophysiology instrument, PatchXpress(TM) marketed by Molecular Devices Corporation and also offers other ion channel related services to drug discovery and development companies.

Tokyo-based Cosmo Bio Co., Ltd. is a major importer and vendor of reagents, instruments and software for biological research and clinical diagnostics. With approximately 200 sales outlets throughout Japan, Cosmo Bio has over 20 years experience providing expert support to Japan's life science research community. Cosmo Bio's Drug Discovery Services team further provides highly focused technical and business support to the pharmaceutical research community by introducing and facilitating access to the world's top suppliers of drug discovery research services.

Photo: http://www.newscom.com/cgi-bin/prnh/20030428/AVIVALOG0AP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comAVIVA Biosciences Corporation

CONTACT: Andrea Ghetti, Sr. Director Pharma Services of AVIVA BiosciencesCorporation, +1-858-552-0888, Press2006@avivabio.com; or Keiichi Yokoyama,Ph.D., Product Communications Department of Cosmo Bio Co., Ltd.+81-(0)3-5632-9616, dds_info@cosmobio.co.jp


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES